Imfinzi Racks Up Another Phase III Failure, But AZ Undeterred

AstraZeneca frustrated again, this time in bladder cancer where Imfinzi gained its first foothold. But its blockbuster success in lung cancer is giving AZ scope to continue with gambles in other tumor types.